Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Valemetostat

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · PHASE 1 TRIAL

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

ClinicalTrials.gov

Phase 1 dose-escalation study with planned enrollment of 24 participants; designed to establish safety and recommended Phase 2 dose, not to demonstrate efficacy or clinical benefit.

PreliminaryExtensive Stage Small Cell Lung Cancer Atezolizumab Valemetostat

Reported

Planned enrollment24

Study phasePhase 1

Primary outcome measureDetermine Phase II dose (RP2D), 1 year

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support